Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients
- 1 January 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Affective Disorders
- Vol. 47 (1-3), 55-62
- https://doi.org/10.1016/s0165-0327(97)00109-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major DepressionThe Journal of Clinical Psychiatry, 1997
- A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholiaJournal of Psychiatric Research, 1996
- Efficacy of venlafaxine treatment in depressed patients with psychomotor retardation or agitation: A metaanalysisHuman Psychopharmacology: Clinical and Experimental, 1995
- Is Baseline Agitation a Relative Contraindication for a Selective Serotonin Reuptake InhibitorJournal of Clinical Psychopharmacology, 1994
- Long-Term Safety and Clinical Acceptability ofJournal of Clinical Psychopharmacology, 1994
- The Relationship of Anxiety and Depression: A Review of the LiteratureThe British Journal of Psychiatry, 1986
- Anxious depressions: Clinical, family history, and naturalistic outcome — comparisons with panic and major depressive disordersJournal of Affective Disorders, 1984
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- Appropriateness of drugs prescribed by primary care physicians for depressed outpatientsJournal of Affective Disorders, 1979
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960